Swiss Visio Retina Research Center

Swiss Visio Retina Research Center is a leading institution dedicated to advancing the understanding and treatment of retinal diseases. With a focus on conditions such as age-related macular degeneration (AMD), diabetic retinopathies, retinal vascular anomalies, and cancer-associated retinopathies, the Swiss Visio Retina Research Center is committed to expanding knowledge and developing innovative therapeutic approaches.

Located at Av. du Servan 38, Lausanne, 1006, CH, the Swiss Visio Retina Research Center’s multidisciplinary team of qualified professionals works diligently to optimize current treatments and explore new possibilities in retinal care. The center's research activities, which began in 2019 and gained recognition in 2022, adhere to the highest standards of quality and excellence, following the ICH Good Clinical Practice Guidelines. Swiss Visio Retina Research Center is a proud member of the European Vision Clinical Research network (EVICR.net) since June 2022 (clinical site no. 136).

Swiss Visio Retina Research Center strives to remain at the forefront of retinal research, contributing significantly to the improvement of patient outcomes and the advancement of the field. We invite the management team at Swiss Visio Retina Research Center to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work and connect with a wider audience.